Schedule 13D ownership disclosure

IMARA Inc.

Security class unavailable · CUSIP: 45249V107

Event date: 2021-12-27

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
Unavailable
Percent of class
14.1000%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001072613-22-000025
Form type
SC 13D/A
Filer
Enliven Therapeutics, Inc.
CIK
CIK 1672619
Filed
Jan 10, 2022
Reporting period
Dec 27, 2021
Description
Schedule 13D beneficial ownership

Explore SEC Filings Hub